An evaluation of Bacillus thuringiensis israelensis (AM65-52) treatment for the control of Aedes aegypti using vehicle-mounted WALS® application in a densely populated urban area of Puerto Rico.

Background: With a shortage of effective options for control of Aedes aegypti in Puerto Rico due to widespread resistance to conventional mosquito adulticides, an alternative approach was investigated to reduce vector populations. In two areas (totaling 144 ha) of the municipality of Bayamón, Puerto Rico, Bacillus thuringiensis israelensis (Bti) AM65-52 WDG was applied at a rate of 500 g/ha using vehicle-mounted aqueous wide-area larvicide spray applications weekly for 4 weeks and then every other week for a further 16 weeks. Bioassay jars were placed in the field to monitor for deposition of Bti droplets in open spaces, and under vegetation and building coverage.

Understanding Information Seeking about the Health of Others: Applying the Comprehensive Model of Information Seeking to Proxy Online Health Information Seeking.

A significant proportion of online health information seeking is related to the health of others, such as the one of family members and friends, instead of an individual's own health. Understanding these behaviors of proxy seekers, i.e.

Field efficacy of granular formulations of Bacillus thuringiensis Israelensis--strain AM65-52 against floodwater mosquitoes in Poland and Germany.

This paper presents results of studies evaluating the efficacy of various granular formulations of VectoBac (Bacillus thuringiensis israelensis de Barjac [Bti] H-14 strain AM65-52) against immature mosquitoes in 2 distinct habitats in Poland and Germany. Meadows intermittently flooded with sewage water in the city of Wroclaw, Poland, provide ideal habitats for immature stages of Aedes caspius, Ae. vexans, and Culex pipiens pipiens.

Evaluation of three microbial formulations against Culex pipiens pipiens larvae in irrigation fields in Wroclaw, Poland.

Two evaluations of microbial mosquito larvicides were conducted in irrigation fields located along the Odra River near the city of Wroclaw, Poland. In the first evaluation, 3 dosages each of Bacillus thuringiensis israelensis (Bti)--VectoBac water dispersible granule (WDG) and VectoBac aqueous suspension formulation (12AS)--and Bacillus sphaericus (Bs)--VectoLex WDG--were tested against larvae of Culex pipiens pipiens. There was little difference between formulations and rates of application between day 2 and 7 following the treatment.

Field trials with tank mixtures of Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus formulations against Culex pipiens larvae in septic tanks in Antalya, Turkey.

Efficacy of tank mixtures of commercial Bacillus thuringiensis subsp. israelensis (Bti) and Bacillus sphaericus (Bs) water-dispersable granule (WDG) formulations was evaluated in septic tanks, against Culex pipiens L. (Diptera: Culicidae) larvae.

Influence of temperature and concentration of VectoBac on control of the salt-marsh mosquito, Ochlerotatus squamiger, in Monterey County, California.

Laboratory susceptibility bioassays were conducted to determine the efficacy of VectoBac TP (Bacillus thuringiensis var. israelensis [Bti]) at different concentrations and temperatures against the salt-marsh mosquito Ochlerotatus squamiger. Bioassays on late 3rd- and early 4th-stage larvae, read at 72 h and 14 degrees C produced an LD90 of 0.